Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

European Diabetes Insulin Pen Market Outlook 2022 - Research and Markets

Research and Markets
Posted on: 03 Oct 17

The "Diabetes Insulin Pen Market Outlook 2022: Top 5 European Countries Opportunity and Demand Analysis, Market Forecast 2017 - 2022" report has been added to Research and Markets' offering.

Diabetes Insulin Pen Market is Anticipated to Surpass US$ 5 Billion Across the Top 5 European Countries: France, Germany, Italy, Spain and United Kingdom by 2022

Diabetes Insulin Pen Market Outlook 2022: Top 5 European Countries Opportunity and Demand Analysis, Market Forecast 2017-2022 examines the market, demand, competitive landscape and trends of the top 5 European markets of the insulin pen market. It provides an all-round analysis of overall number of patients with diabetes and insulin users. It offers information on users of insulin pens, specifically focusing on reusable and prefilled insulin pen users. Market outlook in value terms for the forecasted period for insulin pen market has been detailed in the report. The report also explores detailed description of growth drivers and barriers of the insulin pen market.

The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford and Ypsomed. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the insulin pen market.

Market growth can be attributed to factors such as increasing number of patients with diabetes, high adoption rate, user-friendly design, surging popularity amid consumers, help avoid over/under-dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices.

Long-term Growth Projection and Development:

  • Prefilled (Disposable) insulin pen grasps the dominant share in the top 5 European countries insulin pen market
  • In 2016, there were over 7,800 Thousand users of insulin pen in the top 5 European countries
  • Germany insulin pen market generated more than US$ 1.5 Billion in 2016
  • Spain has shown its potential to become leading #2 market with around 20% market share in 2016

Key Topics Covered:

1. Executive Summary

2. Insulin Pen Market in Top 5 European Countries - Market Overview

3. Insulin Pen Market in Top 5 European Countries - Drivers and Barriers

4. Insulin Pen Market in Top 5 European Countries - Geographical Landscape

5. Key Companies Analysis

  • Eli Lilly
  • Novo Nordisk
  • Owen Mumford
  • Sanofi
  • Ypsomed

For more information about this report visit https://www.researchandmarkets.com/research/bsfr33/diabetes_insulin

View source version on businesswire.com: http://www.businesswire.com/news/home/20170927005487/en/

Business Wire
www.businesswire.com

Last updated on: 03/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.